BONE BIOLOGICS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures
BONE BIOLOGICS CORPORATION (BBLG) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures of 130.21 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures · last filed 2026-05-14
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2026-03-31 was 130.21K shares.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2021-12-31 was 0.00 shares.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2021-09-30 was -54.50K shares, a 2280.04% decline year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for the quarter ending 2021-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2021 was 91.84K shares, a 18.73% decline from fiscal 2020.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2020 was 113.01K shares, a 66.06% decline from fiscal 2019.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2019 was 332.96K shares, a 176.73% increase from fiscal 2018.
- BONE BIOLOGICS CORPORATION share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2018 was 120.32K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | 130.21K shares 10-Q · filed 2026-05-14 | ||||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -54.50K shares derived: sum of 2 quarters · filed 2023-03-30 | -54.50K shares derived: sum of 3 quarters · filed 2023-03-30 | 91.84K shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | -54.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -54.50K shares derived: sum of 2 quarters · filed 2021-11-15 | 91.84K shares 10-Q · filed 2021-11-15 | -70.18K shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 146.34K shares 10-Q · filed 2021-08-16 | -15.68K shares derived: sum of 3 quarters · filed 2022-03-15 | -13.18K shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2021-03-31 | 146.34K shares 10-Q · filed 2021-05-21 | -15.68K shares derived: sum of 2 quarters · filed 2022-03-15 | -13.18K shares derived: sum of 3 quarters · filed 2022-03-15 | 236.70K shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-12-31 | -162.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -159.52K shares derived: sum of 2 quarters · filed 2022-03-15 | 90.36K shares derived: sum of 3 quarters · filed 2022-03-15 | 113.01K shares 10-K · filed 2022-03-15 | 282.53K shares 10-K · filed 2021-04-15 |
| 2020-09-30 | 2.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-15 | 252.37K shares derived: sum of 2 quarters · filed 2021-04-15 | 275.03K shares 10-Q · filed 2021-04-15 | ||
| 2020-06-30 | 249.87K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-15 | 272.53K shares 10-Q · filed 2021-04-15 | |||
| 2020-03-31 | 22.66K shares 10-Q · filed 2021-04-15 | ||||
| 2019-12-31 | 332.96K shares 10-K · filed 2021-04-15 | ||||
| 2018-12-31 | 120.32K shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |